COMPLIANCE WITH HELICOBACTER PYLORI TREATMENT AND RELATED FACTORS IN OUT PATIENTS AT DISTRICT 2 HOSPITAL, HCMC
Main Article Content
Abstract
Introduction: H. pylori has been proved to be related to duodenal and gastric ulcers, which can lead to gastrointestinal bleeding, perforation and gastric cancer. In Vietnam, the prevalence of H. pylori infection in patients with peptic ulcer is from 60 to 80%. However, the effect of H. pylori treatment gradually decreased from 90% in the 1990s to 60-70% after 2010. This rate is related to antibiotic resistance due to the non-compliance of patients. Subjects and method: We recruitedin our prospective, cross-sectional study 249 adults with H. pyloriwho were undergoing an eradication treatment for the first-time. Patients with HP(+)will be invited in study and asked for socio-demographic and clinical information. After 2 weeks of medication, a follow-up visit has been made and the compliance would be assessed. Compliance assessment according to the WHO definition includes 2 criteria: drug compliance and non-alcohol and tobacco compliance. Results: Therates of drugs compliance, nonalcohol-tobacco compliance, and general compliance were respectively 84.74%, 95.58% and 83.13%. There was a statistically significant association between adherence to treatment and: female sex (RR = 1.16; p = 0.011), detected bygeneral check (RR = 1.17; p = 0.033), having comorbidities (RR = 1.17; p = 0.012), be counseled (RR = 1.16; p = 0.016), no history of smoking (RR = 1.87; p < 0.001) and no history of drinking (RR = 2.27; p <0.019). Conclusion: Low compliance indicates a need for improvement in health education and counseling.
Article Details
Keywords
Treatment compliance, H.pylori, eradication treatment, counseling
References
2. Lê Thị Xuân Thảo (2016) "Tuân thủ điều trị trong tiệt trừ Helicobater Pylori ở bệnh nhân viêm loét dạ dày tá tràng". Hội nghị KHKT Đại học Y Dược Thành phố Hồ Chí Minh lần thứ 34.
3. Abbasinazari, M., Sahraee, Z., Mirahmadi, M. (2013) "The Patients' Adherence and Adverse Drug Reactions (ADRs) which are Caused by Helicobacter pylori Eradication Regimens". Journal of clinical and diagnostic research : JCDR, 7, (3), pp. 462-466.
4. Lefebvre, M., Chang, H. J., Morse, A., van Zanten, S. V., Goodman, K. J. (2013) "Adherence and barriers to H. pylori treatment in Arctic Canada". International journal of circumpolar health, 72, 22791-22791.
5. Misiewicz, J. J., Harris, A. W., Bardhan, K. D., Levi, S., O'Morain, C., Cooper, B. T., Kerr, G. D., Dixon, M. F., Langworthy, H., Piper, D. (1997) "One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group". Gut, 41, (6), 735-739.
6. O'Connor, J. A., Taneike, I., O'Morain, C. (2009) "Improving compliance with helicobacter pylori eradication therapy: when and how?". Therapeutic advances in gastroenterology, 2, (5), 273-279.
7. Shakya Shrestha, S., Bhandari, M., Thapa, S. R., Shrestha, R., Poudyal, R., Purbey, B., Gurung, R. B. (2016) "Medication Adherence Pattern and Factors affecting Adherence in Helicobacter Pylori Eradication Therapy". Kathmandu Univ Med J (KUMJ), 14, (53), 58-64.
8. Suzuki, T., Matsuo, K., Ito, H., Sawaki, A., Hirose, K., Wakai, K., Sato, S., Nakamura, T., Yamao, K., Ueda, R., Tajima, K. (2006) "Smoking increases the treatment failure for Helicobacter pylori eradication". Am J Med, 119, (3), 217-224.